Complete sale of oncology portfolio to Servier
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 11 Jan 2021
- Due
- 30 Jun 2021
- Delivered
- 31 Mar 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Complete sale of oncology portfolio to Servier, in a transaction worth up to $2 billion plus royalties, in the second quarter of 2021”
What we found
Evidence strength A What the grades mean
Agios Pharmaceuticals completed the sale of its oncology business to Servier on March 31, 2021, which falls within the second quarter of 2021.
-
A Agios Pharmaceuticals, Inc. 10-Q filed 2021-07-29
“On March 31, 2021, we completed the sale of our oncology business to Servier Pharmaceuticals LLC, or Servier.” ✓ confirmed on the page
Market reaction: the shares moved -3.3% against the S&P 500 over the three sessions around the disclosure (28 Jul 2021 to 2 Aug 2021). What this measures
Checked 24 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Acquisition close
- Indicative materiality
- High rules
- Action
- Complete
- Deliverable
- Sale of oncology portfolio
- In the company’s control
- Medium
- Specificity
- High
- Conditional
- Yes: subject to shareholder approval; satisfaction of regulatory conditions
- Depends on
- Regulatory, Shareholder
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Agios Pharmaceuticals, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-AGIO-021565 · Corrections policy